BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 29992556)

  • 1. The metastatic microenvironment: Melanoma-microglia cross-talk promotes the malignant phenotype of melanoma cells.
    Izraely S; Ben-Menachem S; Sagi-Assif O; Telerman A; Zubrilov I; Ashkenazi O; Meshel T; Maman S; Orozco JIJ; Salomon MP; Marzese DM; Pasmanik-Chor M; Pikarski E; Ehrlich M; Hoon DSB; Witz IP
    Int J Cancer; 2019 Feb; 144(4):802-817. PubMed ID: 29992556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metastatic microenvironment: Brain-derived soluble factors alter the malignant phenotype of cutaneous and brain-metastasizing melanoma cells.
    Klein A; Sagi-Assif O; Izraely S; Meshel T; Pasmanik-Chor M; Nahmias C; Couraud PO; Erez N; Hoon DS; Witz IP
    Int J Cancer; 2012 Dec; 131(11):2509-18. PubMed ID: 22447293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystatin C takes part in melanoma-microglia cross-talk: possible implications for brain metastasis.
    Moshe A; Izraely S; Sagi-Assif O; Prakash R; Telerman A; Meshel T; Carmichael T; Witz IP
    Clin Exp Metastasis; 2018 Aug; 35(5-6):369-378. PubMed ID: 29722001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The melanoma brain metastatic microenvironment: aldolase C partakes in shaping the malignant phenotype of melanoma cells - a case of inter-tumor heterogeneity.
    Izraely S; Ben-Menachem S; Sagi-Assif O; Meshel T; Malka S; Telerman A; Bustos MA; Ramos RI; Pasmanik-Chor M; Hoon DSB; Witz IP
    Mol Oncol; 2021 May; 15(5):1376-1390. PubMed ID: 33274599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocytes facilitate melanoma brain metastasis via secretion of IL-23.
    Klein A; Schwartz H; Sagi-Assif O; Meshel T; Izraely S; Ben Menachem S; Bengaiev R; Ben-Shmuel A; Nahmias C; Couraud PO; Witz IP; Erez N
    J Pathol; 2015 May; 236(1):116-27. PubMed ID: 25639230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term characterization of activated microglia/macrophages facilitating the development of experimental brain metastasis through intravital microscopic imaging.
    Qiao S; Qian Y; Xu G; Luo Q; Zhang Z
    J Neuroinflammation; 2019 Jan; 16(1):4. PubMed ID: 30616691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metastatic microenvironment: Claudin-1 suppresses the malignant phenotype of melanoma brain metastasis.
    Izraely S; Sagi-Assif O; Klein A; Meshel T; Ben-Menachem S; Zaritsky A; Ehrlich M; Prieto VG; Bar-Eli M; Pirker C; Berger W; Nahmias C; Couraud PO; Hoon DS; Witz IP
    Int J Cancer; 2015 Mar; 136(6):1296-307. PubMed ID: 25046141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis.
    Izraely S; Sagi-Assif O; Klein A; Meshel T; Tsarfaty G; Pasmanik-Chor M; Nahmias C; Couraud PO; Ateh E; Bryant JL; Hoon DS; Witz IP
    Int J Cancer; 2012 Sep; 131(5):1071-82. PubMed ID: 22025079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of microenvironment: the role of CCL8 in metastasis formation of melanoma.
    Barbai T; Fejős Z; Puskas LG; Tímár J; Rásó E
    Oncotarget; 2015 Oct; 6(30):29111-28. PubMed ID: 26320180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropilin-2 promotes melanoma growth and progression in vivo.
    Moriarty WF; Kim E; Gerber SA; Hammers H; Alani RM
    Melanoma Res; 2016 Aug; 26(4):321-8. PubMed ID: 26881875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenomic landscape of melanoma progression to brain metastasis: unexplored therapeutic alternatives.
    Marzese DM; Witz IP; Kelly DF; Hoon DS
    Epigenomics; 2015; 7(8):1303-11. PubMed ID: 26638944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCL-X
    Trisciuoglio D; Tupone MG; Desideri M; Di Martile M; Gabellini C; Buglioni S; Pallocca M; Alessandrini G; D'Aguanno S; Del Bufalo D
    Cell Death Dis; 2017 Dec; 8(12):3216. PubMed ID: 29238043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Silencing of SPINT2 Promotes Cancer Cell Motility via HGF-MET Pathway Activation in Melanoma.
    Hwang S; Kim HE; Min M; Raghunathan R; Panova IP; Munshi R; Ryu B
    J Invest Dermatol; 2015 Sep; 135(9):2283-2291. PubMed ID: 25910030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Challenge of Classifying Metastatic Cell Properties by Molecular Profiling Exemplified with Cutaneous Melanoma Cells and Their Cerebral Metastasis from Patient Derived Mouse Xenografts.
    Neuditschko B; Janker L; Niederstaetter L; Brunmair J; Krivanek K; Izraely S; Sagi-Assif O; Meshel T; Keppler BK; Del Favero G; Witz IP; Gerner C
    Mol Cell Proteomics; 2020 Mar; 19(3):478-489. PubMed ID: 31892524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
    Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
    Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MT1-MMP dependent repression of the tumor suppressor SPRY4 contributes to MT1-MMP driven melanoma cell motility.
    Shaverdashvili K; Zhang K; Osman I; Honda K; Jobava R; Bedogni B
    Oncotarget; 2015 Oct; 6(32):33512-22. PubMed ID: 26392417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
    Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
    Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
    Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D
    Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells.
    Zubrilov I; Sagi-Assif O; Izraely S; Meshel T; Ben-Menahem S; Ginat R; Pasmanik-Chor M; Nahmias C; Couraud PO; Hoon DS; Witz IP
    Cancer Lett; 2015 May; 361(1):86-96. PubMed ID: 25725450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NFAT1 enhances the effects of tumor-associated macrophages on promoting malignant melanoma growth and metastasis.
    Liu H; Yang L; Qi M; Zhang J
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30459241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.